SR
Srinivas Ramineni
About Srinivas Ramineni
Data last updated:
Srinivas Ramineni is a Director at Hindustan Therapeutics Private Limited (since 1996), Additional Director at Averx Drugs Private Limited (since 2024) and Additional Director at Indovet Life Sciences Private Limited (since 2023). The companies operate in Pharma, Manufacturing and Real Estate and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹65.45 Cr; the largest is Hindustan Therapeutics Private Limited at ₹54.08 Cr (FY 2025). Earlier, Srinivas Ramineni was a Director at Upi Polymers Private Limited (2012–2017) and Designated Partner at Map Industrial Projects Llp (2012–2017) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Mar 1996 | 1996 | ₹54.08 Cr (FY 2025) | Active | |
| Additional Director | 29 Jan 2024 | 2014 | ₹6.36 Cr (FY 2021) | Active | |
| Additional Director | 12 Jun 2023 | 2020 | ₹5.02 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Jan 2012 | 2010 | ₹4.17 Cr (FY 2022) | Active | |
| Designated Partner | 06 Feb 2012 | 2011 | Active | ||
| Director | 01 Jun 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Srinivas Ramineni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dharma Pracharak Ramineni | 05125190 | Hindustan Therapeutics Private Limited | Director |
| Hanumantha Rao Ratakonda | 02061720 | Hindustan Therapeutics Private Limited | Managing Director |
| Veda Charya Chowdary Ramineni | 02435350 | Hindustan Therapeutics Private Limited | Director |
| Dhana Lakshmi Tirupathi | 07167886 | Averx Drugs Private Limited | Director |
| Nagasekhar Ramineni | 08400770 | Averx Drugs Private Limited | Managing Director |
| Vns Gopal Raju Kurapati | 06943569 | Averx Drugs Private Limited | Director |
| Radhika Ratakonda | 10198664 | Indovet Life Sciences Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivas Ramineni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivas Ramineni
Srinivas Ramineni currently holds 3 directorships: Hindustan Therapeutics Private Limited (Director, since 18 Mar 1996, revenue ₹54.08 Cr (FY 2025)); Averx Drugs Private Limited (Additional Director, since 29 Jan 2024, revenue ₹6.36 Cr (FY 2021)); Indovet Life Sciences Private Limited (Additional Director, since 12 Jun 2023, revenue ₹5.02 Cr (FY 2025)).
Srinivas Ramineni was first appointed on 18 Mar 1996 as Director at Hindustan Therapeutics Private Limited. The most recent appointment on record is 29 Jan 2024 at Averx Drugs Private Limited.
The 3 current companies of Srinivas Ramineni that report revenue have a combined latest revenue of ₹65.45 Cr: Hindustan Therapeutics Private Limited ₹54.08 Cr (FY 2025); Averx Drugs Private Limited ₹6.36 Cr (FY 2021); Indovet Life Sciences Private Limited ₹5.02 Cr (FY 2025).
Srinivas Ramineni held 3 earlier board appointments: Upi Polymers Private Limited (Director, 05 Jan 2012 to 10 Jun 2017); Map Industrial Projects Llp (Designated Partner, 06 Feb 2012 to 23 Mar 2017); Dr. Ramineni Farmers Producer Company Limited (Director, from 01 Jun 2021).
The current boards of Srinivas Ramineni's companies include Dharma Pracharak Ramineni (Hindustan Therapeutics Private Limited), Hanumantha Rao Ratakonda (Hindustan Therapeutics Private Limited), Veda Charya Chowdary Ramineni (Hindustan Therapeutics Private Limited), Dhana Lakshmi Tirupathi (Averx Drugs Private Limited), Nagasekhar Ramineni (Averx Drugs Private Limited), Vns Gopal Raju Kurapati (Averx Drugs Private Limited), among others.